People

Ilise Lombardo

noemapharma.com

Ilise Lombardo is Noema Pharma’s Chief Executive Officer and a board director. She became CEO in June2023 after joining the board in2021. A physician and CNS drug-development executive, she co-founded Arvelle Therapeutics and served as its Chief Medical Officer before its acquisition by Angelini Pharma. Her earlier work includes Kriya Therapeutics, Pfizer, Forum and Axovant, and academic research at Columbia. She trained in psychiatry, neuroreceptor imaging and molecular genetics.